Nektar Therapeutics (NKTR) Earnings Dates, Call Summary & Reports

The P/E ratio of {name} is N/A.

1 Followers

Earnings Data

Report Date

Nov 05, 2026

After Close (Confirmed)

Period Ending

2026 (Q3)

Consensus EPS Forecast

-1.71

Last Year’s EPS

-1.5

Same Quarter Last Year

Strong Buy

Based on 9 Analysts Ratings

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

CH:NKTR Upcoming Earnings

Nektar Therapeutics's next earnings date is estimated for November 5, 2026, based on past reporting schedules.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Nov 05, 2026	2026 (Q3)	-1.71 / -	-1.496	―	―	―
Aug 13, 2026	2026 (Q2)	-1.58 / -0.98	-2.36	58.31% (+1.38)	―
May 07, 2026	2026 (Q1)	-1.27 / -1.46	-2.88	49.44% (+1.42)	―
Mar 12, 2026	2025 (Q4)	-1.98 / -1.42	0.36	-495.56% (-1.78)	―
Nov 06, 2025	2025 (Q3)	-2.15 / -1.50	-2.16	30.74% (+0.66)	―
Aug 07, 2025	2025 (Q2)	-2.42 / -2.36	-3	21.33% (+0.64)	―
May 08, 2025	2025 (Q1)	-2.05 / -2.88	-2.28	-26.32% (-0.60)	―
Mar 12, 2025	2024 (Q4)	-1.63 / 0.36	-2.64	113.64% (+3.00)	―
Nov 07, 2024	2024 (Q3)	-2.39 / -2.16	-2.88	25.00% (+0.72)	―
Aug 08, 2024	2024 (Q2)	-2.22 / -3.00	-3.24	7.41% (+0.24)	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

When does Nektar Therapeutics (CH:NKTR) report earnings?

Nektar Therapeutics (CH:NKTR) is schdueled to report earning on Nov 05, 2026, After Close (Confirmed).

What is Nektar Therapeutics (CH:NKTR) earnings time?

Nektar Therapeutics (CH:NKTR) earnings time is at Nov 05, 2026, After Close (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is the P/E ratio of Nektar Therapeutics stock?

The P/E ratio of Nektar Therapeutics is N/A.

What is CH:NKTR EPS forecast?

CH:NKTR EPS forecast for the fiscal quarter 2026 (Q3) is -1.71.